| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |